Precision BioSciences to Present at Upcoming Scientific Conferences
04 sept. 2019 06h30 HE
|
Precision Biosciences
DURHAM, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its...
Precision BioSciences to Present at Upcoming Investor Conferences
28 août 2019 06h30 HE
|
Precision Biosciences
DURHAM, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its...
Precision BioSciences Reports Second Quarter 2019 Financial Results and Highlights Ongoing Operational Progress
14 août 2019 16h30 HE
|
Precision Biosciences
DURHAM, N.C., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its...
Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United States
18 juil. 2019 06h30 HE
|
Precision Biosciences
DURHAM, N.C., July 18, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary...
Elo Life Systems’ Mario G. Pennisi Awarded BIO Leadership and Legacy Award in Industrial Biotechnology and Agriculture at BIO World Congress
10 juil. 2019 15h00 HE
|
Precision Biosciences
DURHAM, N.C. and BRISBANE, Australia, July 10, 2019 (GLOBE NEWSWIRE) -- Elo Life Systems Inc. (“Elo”), a wholly owned subsidiary of Precision BioSciences, Inc. (Nasdaq: DTIL) announced today that...
Precision BioSciences Appoints Dario Scimeca as General Counsel
12 juin 2019 06h30 HE
|
Precision Biosciences
DURHAM, N.C., June 12, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS®...
Precision BioSciences to Present at Upcoming Investor Conferences
29 mai 2019 06h30 HE
|
Precision Biosciences
DURHAM, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS®...
Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer
14 mai 2019 06h30 HE
|
Precision Biosciences
DURHAM, N.C., May 14, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS® genome...
Precision BioSciences Announces Presentations at the 14th Annual Terrapinn World Advanced Therapies & Regenerative Medicine Congress & Expo 2019
09 mai 2019 06h30 HE
|
Precision Biosciences
DURHAM, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS® genome...
Precision BioSciences Reports First Quarter 2019 Financial Results
29 avr. 2019 16h15 HE
|
Precision Biosciences
DURHAM, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, a genome editing company dedicated to improving life (Nasdaq: DTIL) (“Precision”) through the application of its proprietary...